Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pullinger AL"'
Autor:
Williams TL; Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge U.K., Kuc RE; Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge U.K., Paterson AL; Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, U.K., Abraham GR; Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge U.K.; Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, U.K., Pullinger AL; Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge U.K.; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, U.K., Maguire JJ; Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge U.K., Sinha S; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, U.K., Greasley PJ; Early Clinical Development, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Ambery P; Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Davenport AP; Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Cambridge U.K.
Publikováno v:
Bioscience reports [Biosci Rep] 2024 Jun 26; Vol. 44 (6).
Autor:
Taylor AS; Discovery and Translational Sciences Department, Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, LS2 9JT, UK.; School of Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK., Tinning H; Discovery and Translational Sciences Department, Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, LS2 9JT, UK., Ovchinnikov V; School of Life Sciences, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, NG7 2RD, UK., Edge J; Discovery and Translational Sciences Department, Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, LS2 9JT, UK., Smith W; Discovery and Translational Sciences Department, Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, LS2 9JT, UK.; Leeds Fertility, Leeds Teaching Hospitals NHS Trust, York Road, Seacroft, Leeds, LS14 6UH, UK., Pullinger AL; Discovery and Translational Sciences Department, Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, LS2 9JT, UK., Sutton RA; Discovery and Translational Sciences Department, Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, LS2 9JT, UK., Constantinides B; School of Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.; Modernising Medical Microbiology Consortium, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, UK., Wang D; LeedsOmics, University of Leeds, Leeds, LS2 9JT, UK.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK., Forbes K; Discovery and Translational Sciences Department, Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, LS2 9JT, UK., Forde N; Discovery and Translational Sciences Department, Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, LS2 9JT, UK. n.forde@leeds.ac.uk., O'Connell MJ; School of Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK. drmary.oconnell@gmail.com.; School of Life Sciences, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, NG7 2RD, UK. drmary.oconnell@gmail.com.
Publikováno v:
Communications biology [Commun Biol] 2023 Apr 26; Vol. 6 (1), pp. 459. Date of Electronic Publication: 2023 Apr 26.
Autor:
Macrae RGC; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Level 6, Addenbrooke's Centre for Clinical Investigation, Box 110, Cambridge CB2 0QQ, UK.; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Colzani MT; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Williams TL; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Level 6, Addenbrooke's Centre for Clinical Investigation, Box 110, Cambridge CB2 0QQ, UK., Bayraktar S; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Kuc RE; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Level 6, Addenbrooke's Centre for Clinical Investigation, Box 110, Cambridge CB2 0QQ, UK., Pullinger AL; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Level 6, Addenbrooke's Centre for Clinical Investigation, Box 110, Cambridge CB2 0QQ, UK.; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Bernard WG; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Robinson EL; School of Medicine, Division of Cardiology, University of Colorado Denver, Aurora, CO, USA., Davenport EE; Wellcome Sanger Institute, Cambridge, UK., Maguire JJ; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Level 6, Addenbrooke's Centre for Clinical Investigation, Box 110, Cambridge CB2 0QQ, UK., Sinha S; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Davenport AP; Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke's Hospital, Level 6, Addenbrooke's Centre for Clinical Investigation, Box 110, Cambridge CB2 0QQ, UK.
Publikováno v:
Cardiovascular research [Cardiovasc Res] 2023 Mar 31; Vol. 119 (2), pp. 587-598.